Objective. To conduct a meta-analysis of the effects on stillbirths and on early and late neonatal mortality of supplementation during pregnancy with multiple micronutrients compared with iron-folic acid in recent randomized, controlled trials.
Introduction
The World Health Organization (WHO) recommends universal distribution of iron-folic acid supplements to all pregnant women in developing countries [1] . Because many women face additional micronutrient deficits, particularly during pregnancy, repletion of pregnant women with minerals and vitamins has been suggested as a way to further improve birth outcomes in countries with a high burden of undernutrition [2] . Daily multiple micronutrients during pregnancy have been shown to reduce the number of low-birthweight (LBW) and small-for-gestational-age (SGA) babies and the incidence of maternal anemia [3] . A recent meta-analysis of multiple micronutrient supplementation during pregnancy reported a small, statistically significant increase in birthweight when compared with iron-folic acid supplementation, but there was no effect on the incidence of preterm birth [4] . Another meta-analysis showed reductions in anemia and iron deficiency and several other micronutrient deficiencies with the use of multiple micronutrients [5] .
If multiple micronutrients affect fetal growth, particularly SGA births [6] , a direct beneficial effect on perinatal or neonatal survival can be hypothesized. A systematic review of nine trials did not find a significant difference in perinatal mortality when multiple micronutrient supplementation was compared with supplementation with one or two micronutrients, iron-folic acid supplementation, no supplementation, or placebo [3] . However, two trials in Nepal reported nonsignificant increases in perinatal and neonatal deaths associated with multiple micronutrient supplementation compared with supplementation with ironfolic acid only] [7] . Although these results have been called into question [8, 9] , the possibility of adverse outcomes in relation to multiple micronutrient supplementation certainly warrants further investigation.
At the time of the systematic review conducted by Haider and Bhutta [3] , a number of trials of multiple micronutrient supplementation were still ongoing. The present study updates the review and assesses the effect of supplementing pregnant women with a daily multiple micronutrient tablet compared with iron-folic acid on stillbirths, early and late neonatal mortality, and perinatal mortality.
Methods

Search protocol and study review
Details of the search strategy and study review are reported elsewhere [10] . In brief, findings are reported from randomized, controlled trials supplementing pregnant women with daily multiple micronutrients. For studies with more than one intervention or control arm, only one comparison group was selected [10] . Table 1 lists the 12 trials included in this review. In brief, nine studies [6, [11] [12] [13] [14] [16] [17] [18] [19] used the UNICEF/ United Nations University/World Health Organizationrecommended daily composition of the multiple micronutrient tablet UNIMMAP (United Nations International Multiple Micronutrient Preparation), while the studies in Mexico [21] , Nepal (Sarlahi) [15] , and Zimbabwe [20] used slightly different preparations. UNIMMAP contains 30 mg of iron, 15 mg of zinc, 2 mg of copper, 65 μg of selenium, 150 μg of iodine, 800 µg RE of vitamin A, 1.4 mg of vitamin B 1 , 1.4 mg of vitamin B 2 , 400 μg of folic acid, 18 mg of niacin, 1.9 mg of vitamin B 6 , 2.6 μg of vitamin B 12 , 70 mg of vitamin C, 200 IU of vitamin D, and 10 mg of vitamin E. The studies in Nepal (Sarlahi) and Mexico used multiple micronutrients containing 60 mg of iron, and in Zimbabwe iron-folic acid was not included in the multiple micronutrients but was supplied separately as part of routine antenatal care.
The control regimen consisted of 60 mg of iron and 400 μg of folic acid, except for the studies in Indonesia (Lombok) and Bangladesh, which used 30 mg of iron. Women in Zimbabwe received the routine antenatal prescription of iron-folic acid. Six trials were cluster randomized and six used individual randomization.
Statistical methods
From the selected studies, data were extracted on the number of live births and stillbirths and on early and late neonatal mortality. The coding of data on fetal loss, stillbirths, and live births was accepted from that reported in the data for each study. A stillbirth was defined as the death of a fetus after 28 weeks or more of gestation but before delivery of the baby's head, which is consistent with the definition generally used in developing countries. Early neonatal death was defined as death of a live-born infant within 7 completed days after birth. Late neonatal death was defined as death of an infant between 8 and 28 completed days after birth. Data on stillbirths and early neonatal deaths were also pooled as perinatal deaths, because early neonatal deaths may be wrongly registered as stillbirths [22] . The denominators for the rates of stillbirth, early neonatal death, late neonatal death, and perinatal death are all births (live births and stillbirths), all live births, all neonates surviving after the first week, and all births, respectively. Women were excluded from the analysis if they were known to be HIV positive, if they had multiple pregnancies or fetal loss, or if it was not known whether their infant was born dead or alive. Only one pregnancy was included for each woman.
Statistical analyses and meta-analyses were performed with the use of Stata 10. The overall effect of multiple micronutrient supplementation on the risk of stillbirth, early neonatal death, perinatal death, and late neonatal death was assessed. Crude mortality rates in intervention and control arms, with 95% confidence intervals adjusted for clustering where appropriate, were also reported. Odds ratios with 95% confidence intervals were used as a measure of the effect of multiple micronutrient supplementation on mortality. Random-effects models were used to calculate the pooled odds ratio for multiple micronutrient supplementation compared with controls, with adjustment for cluster design where appropriate. The results were presented based on analyses using random-effects models because of the differences between the study populations in level of mortality, intervention and control regimens, duration of intervention, and dietary intake. Heterogeneity between studies was measured by the I-square statistic and was tested for significance by using a chi-square test on the Q statistic. Because the review was heavily weighted toward the large Indonesia (Lombok) study [14] , an a priori sensitivity analysis was performed by removing this study from the meta-analysis.
Results
Levels of mortality
There were marked differences between studies in the rates of stillbirth, early neonatal death, and late neonatal death ( show the results of the meta-analysis for stillbirth and early neonatal and perinatal mortality. With a randomeffects model, multiple micronutrient supplementation was not associated with the rate of stillbirth (OR = 1.01; 95% CI, 0.88 to 1.16), but there was a nonsignificant 23% increase in early neonatal mortality (OR = 1.23; 95% CI, 0.96 to 1.59) and a nonsignificant 11% increase in perinatal mortality (OR = 1.11; 95% CI, 0.93 to 1.33). Between-study heterogeneity was moderate for perinatal mortality (I 2 = 46%, p = .07) and early neonatal mortality (I 2 = 34%; p = .15) but low for stillbirths (I 2 = 3%, p = .42). Excluding the large Indonesia (Lombok) study increased all estimates of relative risk. The subsequent odds ratios for stillbirth, early neonatal death, and perinatal death were 1.12 (95% CI, 0.93 to [20] 358 (2) 357 (4) ----Mexico [21] 302 ( 
Late neonatal mortality
Data on late neonatal mortality were available for eight studies, which included 22,396 children whose mothers received multiple micronutrient supplementation and 22,003 children in the control arm. The pooled data showed a nonsignificant 6% reduction in late neonatal mortality (OR = 0.94; 95% CI, 0.73 to 1.23) ( fig. 7) .
Heterogeneity was low (I 2 = 0%; p = .75) and sensitivity analysis altered the odds ratio slightly (OR = 1.01; 95% CI, 0.64 to 1.60).
Discussion
This meta-analysis provides coherent evidence that multiple micronutrient supplementation does not result in any reduction in the rates of stillbirth or in early or late neonatal death. However, after exclusion of the large Indonesian study from the analysis, the data were consistent with an increase in the risk of early neonatal and perinatal mortality in women taking multiple micronutrient supplements during pregnancy compared with those taking iron-folic acid.
The lack of an effect of multiple micronutrient supplements on perinatal or neonatal survival-and the possibility of increased early neonatal and perinatal mortality in women taking multiple micronutrient supplements in some settings-needs to be scrutinized very carefully. This finding is surprising, given that multiple micronutrient supplementation does result in small increases in birthweight [4] . It was expected that there would be a direct beneficial effect on early neonatal and perinatal survival. Increased survival of infants who would otherwise have died in utero is unlikely, since multiple micronutrient supplementation was not associated with increased rates of preterm birth [4] or stillbirth. It could be argued that newborns in the control arm had enhanced survival because most mothers in the control arm received higher amounts of iron than those in the group receiving multiple micronutrients. There is no evidence, however, that routine iron supplementation in pregnancy improves health outcomes for babies [23] . Huffman and colleagues [8] suggested that the earlier Nepal findings might be due to a misclassification of stillbirths as neonatal deaths. It was for that reason that perinatal mortality (pooled stillbirths and early neonatal deaths) was assessed, rather than reporting only on neonatal mortality. Increased asphyxia of children born at the upper end of the birthweight distribution [7] may partly explain the adverse effects of multiple micronutrient supplementation on perinatal mortality. In Nepal, children whose mothers had received multiple micronutrients were reported to have a 60% higher risk of birth asphyxia [24] .
Meta-analyses have inherent limitations. First, the sample sizes of the trials included in this analysis varied, and the results were more likely to be affected by the trials with larger sample sizes. However, the only study powered to examine effects on mortality (the Lombok, Indonesia study) also failed to find a statistically significant effect of multiple micronutrient supplementation on perinatal or neonatal survival [14] . Second, there was significant heterogeneity among studies in perinatal mortality, although the source of this heterogeneity is difficult to ascertain. The study populations differed substantially in terms of nutritional status, reproductive history, and the timing and duration of multiple micronutrient supplementation, all of which may affect the size of the effect of multiple micronutrients on perinatal mortality. The effects of supplements have been found to differ in HIV-infected and -uninfected pregnant women in Tanzania [25] , a result suggesting that the burden of infectious diseases may affect nutritional requirements and the size of the effect of multiple micronutrients.
Intervention trials have now expanded the range of endpoints to include neonatal morbidity [24] , mortality after the first month of life [14, 26] , infant growth and development, and health outcomes later in childhood [27] . In Lombok, Indonesia, early infant mortality after the first month of life was 30% lower in the group receiving multiple micronutrients than in the iron-folic acid group [14] . In Nepal, children whose mothers had taken multiple micronutrients during pregnancy were heavier and of greater body size at the age of 2.5 years than those born to mothers who had received only iron-folic acid [27] . In another study in Nepal, multiple micronutrient supplementation did not improve symptoms of neonatal morbidity, and reported birth asphyxia was higher in the group receiving multiple micronutrients [24] . In the present analysis, data were not available on survival beyond 1 month, and it was not possible to expand the meta-analysis beyond the neonatal period.
It has been suggested that higher doses of multiple micronutrients may be required in malnourished populations [25] . However, the one study that involved a supplement containing twice the RDA of vitamin E and 6 to 10 times the RDAs for several B vitamins and vitamin C in HIV-uninfected pregnant women in Tanzania, and that was powered for effects on fetal death, also found no effect of the supplement on the rate of stillbirth or perinatal mortality [25] . It may be that multiple micronutrient supplementation before conception rather than during pregnancy is the way forward. Periconceptional folic acid supplementation, for example, reduces the incidence of neural tube defects [28] , and there is growing evidence that maternal undernutrition in the periconceptional period increases the risk of preterm delivery [29, 30] and reduces fetal growth, even if nutrition improves later in pregnancy. Future research should include studies of maternal nutrient repletion before pregnancy.
What are the implications of our findings for public health? Any suggestion of harm must be carefully weighed against evidence of potential gain [9] . Improving micronutrient intake during pregnancy contributes to reduced micronutrient deficiencies in mothers and small increases in birthweight, and there is some evidence that infant survival after the first month may be improved. However, multiple micronutrient supplementation in pregnancy did not lead to a gain in perinatal survival in the pooled results of 11 studies of women receiving multiple micronutrient supplementation, and multiple micronutrients may increase the risk of birth asphyxia. Three-quarters of neonatal deaths happen in the first week of life, and the burden of mortality in the early neonatal period is much greater than that in later infancy. There has also been little progress in reducing deaths during the perinatal period [31] . Given the limited resources available for public health in poor countries, attention should focus on interventions that are known to positively reduce the burden of stillbirths and early neonatal mortality. On current evidence, multiple micronutrient supplementation started in mid-pregnancy is not one of them. Success in reducing perinatal deaths is possible through outreach and community care, including health education to improve home care practices, to create demand for skilled care, and to improve care-seeking. Expansion of skilled care for babies and mothers is essential to achieve the reduction in neonatal deaths needed to meet the Millennium Development Goal for child survival.
